Intrinsic Therapeutics Launches Innovative Barricaid Narrow Anchor to Minimize Reherniation Risks Post Back Surgery Intrinsic Therapeutics has unveiled the Barricaid® Narrow Anchor, a groundbreaking device aimed at mitigating reherniation following back surgery. The new design enhances safety and efficiency.

Intrinsic Therapeutics Launches Innovative Barricaid Narrow Anchor to Minimize Reherniation Risks Post Back Surgery #USA #Boston #Intrinsic_Therapeutics #Barricaid #Back_Surgery